by MBrace Therapeutics | Nov 10, 2023 | Uncategorized
Oversubscribed Series B round led by TPG includes prominent group of new and existing investors, bringing total raised to-date to over $110 million Funding supports rapid clinical development of targeted ADC therapeutics in difficult-to-treat cancers Chris LeMasters...
